AMARILLO, TX – Every supplier will face a device recall event. Regardless of the equipment they provide, suppliers often find themselves at the center of patient communications, manufacturer directives, reimbursement questions, and regulatory obligations. When a recall comes, a supplier’s efforts can significantly improve patient safety, reduce legal risk, and maintain customer satisfaction.
This article describes several common issues that arise after a recall notice. It includes a summary of the practical steps DME suppliers should take to address a recall. An experienced healthcare attorney can help navigate these important steps and preserve the health and safety of patients while also protecting the business from the risks that can arise from faulty equipment under a recall notice.
- Quickly Determine the Nature and Scope of the Recall
The first step a supplier should take is understanding exactly what has been recalled and why. Suppliers should review the manufacturer’s recall notice, FDA communications, and applicable correction or removal instructions.
Recalls vary in severity. Some address issues that create a reasonable likelihood of serious health consequences or death (Class I), while others are low-severity recalls that are not likely to cause adverse health consequences. Remedies also vary: some recalls involve removal and replacement of faulty devices, while others can be addressed through software updates, labeling corrections, inspection procedures, or replacement components. Where serious hazards exist and repair or replacement is not logistically feasible in a short time, manufacturers may issue interim-use instructions to mitigate risk while they work to address the issue.
Regardless of the recall severity, the supplier should immediately identify:
- The specific device or component subject to the recall.
- Whether the recall is voluntary or FDA-classified.
- The recommended corrective action and whether the supplier may make the correction.
- Whether replacement products are available.
When a supplier has furnished a large number of devices subject to a recall, a centralized recall response team is the best approach. This ensures a coordinated and consistent response that involves operations, compliance, customer service, and clinical personnel.
- Identify Affected Patients and Assess Continued Use of the Device
The most significant challenge suppliers face is determining which patients received affected devices and handling the logistics of communicating with each as promptly as possible. Maintaining accurate asset tracking and serial number documentation before a recall occurs is one of the most effective ways to reduce operational disruption.
Patients may learn of the recall before the supplier can reach them and may call asking whether they should stop using the recalled equipment immediately.
Continued use of a device under recall depends on the manufacturer’s instructions and the patient’s clinical condition. Certain recalls involve risks that are significant but not necessarily greater than the risk of discontinuing therapy. For example, in several respiratory-device recalls, manufacturers and regulators advised patients to continue therapy pending consultation with their physician because the risks associated with untreated sleep apnea or respiratory failure could exceed the recall-related risk.
- Communicate Clearly and Consistently
Documentation of all patient communications is crucial to ensure patient safety and protect the supplier’s business interests.
Patients typically want answers to questions like:
- Is the device safe?
- Can I continue using the device?
- When will I receive a repair, replacement, or refund?
Suppliers often cannot rely on the manufacturer’s messaging alone. Suppliers benefit when they prepare standardized call scripts, FAQs, letters, and website content to ensure consistent messaging.
Replacement timelines can be uncertain, frustrating both suppliers and patients. Suppliers benefit from transparency and clarity about the uncertainty rather than providing estimates that may later prove inaccurate.
- Manage Replacement and Repair Logistics
Many recalls involve a shortage of replacement devices. Demand often exceeds the immediately available inventory.
To address this issue, suppliers may need to:
- Conduct triage and prioritize patients based on clinical need.
- Maintain waiting lists.
- Track replacement requests.
- Document manufacturer registration submissions.
- Coordinate closely with manufacturers regarding allocation schedules.
If temporary substitute equipment is available, suppliers should evaluate whether deployment is clinically appropriate and financially feasible. Manufacturers may also authorize suppliers to conduct certain repairs; when they do, suppliers should confirm the scope of that authorization and document each repair performed.
- Evaluate Reimbursement and Billing Implications
Recalls can create difficult reimbursement questions.
Common issues include:
- Whether replacement equipment is billable.
- Whether rental payments should continue.
- Whether payors will cover substitute equipment.
- Whether the supplier can recover costs from the manufacturer.
Suppliers should review Medicare, Medicaid, and commercial payor requirements before submitting claims associated with recall remediation.
The manufacturer is often responsible for costs incurred from the recall. That liability can stem from contractual warranties or indemnification obligations. Suppliers should carefully evaluate which party is financially responsible for costs incurred as a result of the recall. Improper billing to an insurance plan can create audit and overpayment risks.
- Preserve Documentation and Evidence
Recalls can lead to product liability litigation, warranty disputes, insurance claims, and regulatory investigations.
Suppliers should preserve:
- Recall notices.
- Manufacturer correspondence.
- Patient communications.
- Service records.
- Replacement records.
- Returned-device tracking information.
When a patient reports an injury, malfunction, or adverse event, the supplier should take steps to preserve the device and maintain chain-of-custody documentation. Destroying, altering, or returning a device before potential claims are evaluated can create substantial evidentiary issues.
- Monitor Adverse Event Reporting Obligations
A recall may reveal previously unknown device problems. Suppliers should ensure that complaints and incident reports are routed through established quality and compliance processes.
Although manufacturers bear primary reporting responsibilities in many circumstances, suppliers should understand their obligations under applicable FDA regulations, accreditation standards, contractual requirements, and internal policies.
Potentially serious incidents should be escalated promptly for clinical and legal review.
- Evaluate Contractual Rights Against Manufacturers
Recalls frequently impose significant costs on suppliers, including labor expenses, shipping costs, replacement efforts, customer-service demands, and lost revenue.
Suppliers should review manufacturer and distribution agreements to determine:
- Indemnification rights.
- Warranty protections.
- Recall reimbursement provisions.
- Cost-sharing obligations.
- Insurance requirements.
Many supplier agreements inadequately address recall-related expenses. A recall often highlights the importance of negotiating stronger recall allocation provisions in future contracts.
Conclusion
When confronting a recall, a supplier faces logistical challenges, patient-safety concerns, operational burdens, reimbursement questions, and potential legal exposure. Suppliers can mitigate these challenges by promptly identifying affected patients, communicating effectively, documenting all communications and actions taken, preserving evidence, and coordinating closely with manufacturers and clinicians. These steps can put any supplier in the strongest position to protect both patients and the business.
The most successful recall responses are those driven by preparation. Detailed documentation, clear communication protocols, and carefully negotiated manufacturer agreements can transform a potentially disruptive recall into a manageable compliance event while maintaining patient trust and continuity of care.
Matthew D. Earl, Esq. is a healthcare attorney at Brown & Fortunato, a national, full-service law firm dedicated to providing exceptional legal services to its clients in the healthcare industry. Earl regularly advises DME suppliers, pharmacies, manufacturers, and other healthcare providers on regulatory compliance, reimbursement issues, and operational risk management. He also represents providers in payer audits, False Claims Act litigation, and federal and state investigations, including matters involving the DOJ, OIG, and state attorneys general. With deep experience navigating the healthcare regulatory landscape, Earl delivers practical, business-focused guidance that helps healthcare companies manage compliance challenges, reduce risk, and achieve their operational and growth objectives. Connect with Matt at (385) 509-6583 or [email protected].
Jeffrey S. Baird, JD, is chairman of the Health Care Group at Brown & Fortunato, PC, a law firm with a national health care practice based in Texas. He represents pharmacies, infusion companies, HME companies, manufacturers and other health care providers throughout the United States. Mr. Baird is Board Certified in Health Law by the Texas Board of Legal Specialization and can be reached at (806) 345-6320 or [email protected].
